ODDB.org: Open Drug Database

Teva Pharma AG - Irinotecan-Teva liquid 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	59217	Sequence	02
Product name	Irinotecan-Teva liquid 100 mg/5 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description
Introduction of Sequence	06.05.2009

Composition

irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 0.431.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100mg / 5ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100 mg

Inactive agents	Dose



Sorbitol	225mg / 5ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
006		91.42	115.85	A	SL	No

2025	©ywesee GmbH